Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Chronic viral infections provoke a war of attrition between cytotoxic T cells (the CD8+ subclass) of the immune system and infected host cells. Although the CD8+ T cell response gradually whittles away at the viral load, the cells progressively become "exhausted" and lose function during a chronic infection (1). This exhaustion becomes more severe in the absence of helper CD4+ T cells, potentially leading to viral persistence and loss of virus-specific CD8+ T cells (1, 2). But how do CD4+ cells help? Three reports in this issue, by Elsaesser et al. on page 1569 (3), Yi et al. on page 1572 (4), and Fröhlich et al. on page 1576 (5), suggest an unexpected role for a specific cytokine produced by CD4+ T cells called interleukin-21 (IL-21) in controlling chronic viral infections.
Laboratory Medicine and Pathology, Center for Immunology, University of Minnesota, Minneapolis, MN 55455, USA.
The editors suggest the following Related Resources on Science sites:
In Science Magazine
Anja Fröhlich, Jan Kisielow, Iwana Schmitz, Stefan Freigang, Abdijapar T. Shamshiev, Jacqueline Weber, Benjamin J. Marsland, Annette Oxenius, and Manfred Kopf (19 June 2009) Science324 (5934), 1576.
[DOI: 10.1126/science.1172815] |Abstract »|Full Text »|PDF »|Supporting Online Material »